サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663432

造影剤の世界市場：モダリティ別・投与経路別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Contrast Media Market, By Product, By Modality, By Route of Administration, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
造影剤の世界市場：モダリティ別・投与経路別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年02月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

造影剤の市場規模は2024年に65億1,420万米ドルとなり、2025年から2032年にかけてCAGR 8.00%で拡大

造影剤の市場力学

医療費の増加

市場拡大の主な要因は、医療費の増加です。近年、多くの国で医療費が顕著に増加していることから、同市場はその影響を受けると予測されます。例えば、予測期間中、様々な画像診断における造影剤の需要は、可処分所得の増加による医療施設支出の予想成長によって牽引されるであろう。例えば、米国のGDPに占める医療費の割合は、2019年の17.6%から2022年には18.3%に上昇しました。さらに、医療費はブラジルやインドを含む多くの国で上昇しています。したがって、高度な医療設備の導入は、医療費の上昇に大きく影響されます。したがって、造影剤市場の拡大は、医療インフラを改善し、患者の増大するニーズを満たし、最先端の医療を提供するために、各国が医療費を増加させることが原動力になると予測されます。

造影剤市場：主な考察

リサーチアナリストの分析によると、世界市場は予測期間 (2025-2032年) に約8.00%のCAGRで年間成長すると予測されます。

製品別では、2024年にはヨード剤が最大の市場シェアを示すと予測されています。

投与経路別では、2024年には静脈内投与が主要セグメントとなった。

用途別では、神経疾患が2024年の主要セグメントでした。

最終用途別では、病院が2024年の主要セグメントでした。

地域別では、北米が2024年の売上高でトップでした。

造影剤市場：セグメンテーション分析

世界の造影剤市場は、製品、モダリティ、投与経路、用途、最終用途、地域によって区分されます。

市場を製品別に見ると、マイクロバブル、ヨード、ガドリニウムベース、バリウムベースに分類されます。2024年には、CTやX線技術の普及に加え、より良い診断のために安定した非イオン性ヨード物質が入手しやすくなったことから、ヨード系カテゴリーが市場を独占しています。バリウム系造影剤は経口や直腸投与に使用されることもありますが、ヨード系造影剤は通常静脈投与されます。ヨード系造影剤を使用することで、CTやX線画像が改善されます。さらに、脳、軟部組織、動脈・静脈、内臓、消化管などの撮影を改善するためにも使用されます。がん以外にも、ヨード系造影剤は神経、消化器、腎臓、心臓血管、筋骨格系など幅広い適応症に使用できます。

用途に基づき、市場は筋骨格系疾患、がん、腎臓疾患、心血管疾患、消化器疾患、神経疾患、その他に分けられます。2024年には、神経系疾患が圧倒的な市場シェアを占めています。MRI造影剤はCTよりも優れた脳構造の画像を生成するため、神経疾患の中枢神経系の診断評価で使用が奨励されています。ガドリニウム系造影剤は、脱髄、炎症、腫瘍性病変の描出に使用されます。MRIの3件に1件は、画質向上のためにガドリニウム系造影剤が使用されています。これらの造影剤は、血管、炎症、腫瘍を見えやすくすることで、診断の精度を高めます。米国で神経疾患の診断に最もよく使用されている大環状ガドリニウム系造影剤は、Gadavist、Dotarem、Prohanceの3種類です。2歳以上の成人および小児は、脳、脊椎および関連組織の異常な血管を見るために、これらの造影剤を静脈注射することができます。

造影剤市場：地域別分析

2024年、造影剤の世界市場は北米が支配的な地位を占めています。政府と非政府組織の両方から生物医学研究への資金援助が増加したことが、市場の上昇に大きく寄与しています。例えば、2022年10月3日、SNMMIは、小葉乳腺新形成に対応する核医学イメージング研究開発のために10万米ドルを授与すると発表しました。これは大幅な拡大につながると予想されます。この分野における資金調達の増加は、多くの研究プロジェクトを可能にし、造影剤を必要とする新製品リリースのためのより創造的なアイデアにつながります。さらに、医療機器に投資する新興企業の増加も、この地域の市場収益を押し上げる要因となっています。

しかし、予測期間を通じて、アジア太平洋地域のCAGRが最も速いと予想されています。これは、医療インフラが整備され、早期診断の重要性に対する人々の意識が高まっているためです。さらに、この地域の市場収益を押し上げているもう1つの理由は、がん、神経疾患、腸疾患、心血管疾患 (CVD) などの慢性疾患の有病率が上昇していることです。例えばインドでは、世界保健機関 (WHO) によると、非伝染性疾患が全死亡の63%を占め、そのうち心血管疾患が27%を占めています。さらに、革新的な分子イメージング技術の創出数は、新興企業の増加によって大きな影響を受けると予想されます。また、予測期間を通じて、これらの新興企業は市場拡大を加速させると予想されます。

造影剤市場：競合情勢

Bayer AG、General Electric Company、Jodas Expoim Pvt. Ltd.、Lantheus、Guerbetなどの大手企業は、M&Aや提携などの戦略を駆使して市場シェアを拡大しています。さらに、新製品を発売しています。顧客基盤と市場シェアを国際的に拡大するため、大手企業はM&Aを進めています。買収により、企業はより優れたポートフォリオを手に入れ、地理的な範囲も広がり、足跡を拡大することができます。疾患適応症の拡大は、企業が特定の人口集団の信頼を得ることを可能にするため、この業界では一般的です。特定の適応症の承認を通じて、企業は自社製品の採用を促進し、特定の患者層をターゲットにすることができます。例えば、GEヘルスケアは2023年4月、磁気共鳴画像法 (MRI) 用の大環状非イオン性ガドリニウム系造影剤 (GBCA) であるピクソスキャン (ガドブトロール) を発売し、造影剤の幅を広げました。Pixxoscanは、DCP (Decentralized Procedure) による規制当局の評価を経て、オーストリアで販売許可を取得しました。

最近の動向

2024年8月Bayer AGは、より優れた弛緩性と安全性プロファイルを有する新しいガドリニウムベースの造影剤の第III相臨床試験が完了したと発表しました。この造影剤により、神経用途のMRIイメージング能力が向上する可能性があります。

2024年4月GEヘルスケアは、造影剤の投与量と時間を最適化することで画質を向上させ、造影剤腎症のリスクを低減することを目的とした、AIを搭載した新しい造影剤注入装置を発表しました。

2024年3月米国食品医薬品局 (FDA) は、ランテウス・ホールディングス・インク (Lantheus Holdings Inc) による、心エコー検査不良の小児患者への使用を目的とした超音波増強剤DEFINITY (Perflutren Lipid Microsphere) の追加新薬承認申請 (sNDA) を承認。

2023年6月米国食品医薬品局は、ヨードベースの造影剤Iopromide-300および-370 (Ultravist) を承認。マンモグラフィや超音波検査に加えて、成人の既知または疑いのある乳房病変の描出に使用できます。

目次

第1章 造影剤市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 造影剤の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 造影剤市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 造影剤市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 造影剤の市場情勢

  • 造影剤の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 造影剤市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • マイクロバブル
    • ヨウ素化
    • ガドリニウムベース
    • バリウムベース

第8章 造影剤市場：モダリティ別

  • 概要
    • セグメント別シェア分析：モダリティ別
    • 超音波
    • X線/コンピューター断層撮影
    • 磁気共鳴画像

第9章 造影剤市場：投与経路別

  • 概要
    • セグメント別シェア分析：投与経路別
    • 経口投与
    • 静脈内
    • 直腸経路

第10章 造影剤市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 筋骨格障害
    • がん
    • 腎臓疾患
    • 心血管疾患
    • 胃腸障害
    • 神経疾患
    • その他

第11章 造影剤市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院
    • 画像診断センター
    • その他

第12章 造影剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析：造影剤業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Bayer AG
    • General Electric Company
    • Jodas Expoim Pvt. Ltd.
    • Lantheus
    • Guerbet
    • SANOCHEMIA Pharmazeutika GmbH
    • TAEJOON PHARM Co. Ltd.
    • Beijing Beilu Pharmaceuticals Company Limited
    • Bracco SpA
    • iMAX Diagnostic Imaging Limited
    • JB Chemicals &Pharmaceuticals Limited
    • Nano Therapeutics Pvt Ltd
    • Trivitron Healthcare
    • Others

第14章 AnalystViewの全方位的分析

目次
Product Code: ANV4669

REPORT HIGHLIGHT

Contrast Media Market size was valued at US$ 6,514.2 Million in 2024, expanding at a CAGR of 8.00% from 2025 to 2032.

A contrast medium is a material that is used in medical imaging to improve the contrast of bodily fluid structures. Contrast media improve the visibility of the targeted blood vessels, tissues, or structures. In addition to emitting radiation, contrast media also change or absorb incoming electromagnetic or ultrasonic waves. MRIs and ultrasounds typically use one of the following contrast agents: barium-based, iodinated, gadolinium-based, or microbubble. Growing alliances and acquisitions among companies to launch new products, rising rates of cancer, neurological and cardiovascular illnesses, and new developments in contrast media are some of the reasons that are expected to propel the worldwide contrast media market throughout the forecast period. Moreover, some of the main factors propelling the growth of the contrast media market throughout the forecast period include rising incidence and prevalence of cancer and heart illnesses, growing demand for image-guided diagnostics and procedures, and technical improvements in medical imaging techniques. However, the high cost of the contrast media injectors and the negative consequences of using contrast media, such as bluish skin, vomiting, and stomach pains, are some of the factors holding back the growth of the worldwide contrast media market throughout the forecast period.

Contrast Media Market- Market Dynamics

Rise in healthcare spending

The primary driver of the market's expansion is the rise in healthcare spending. The market is anticipated to be impacted by the notable rise in medical expenditures in a number of nations in recent years. For instance, during the projection period, the demand for contrast media in various diagnostic imaging would be driven by the anticipated growth in healthcare facility spending due to the rise in disposable income. For example, healthcare expenditures made up 18.3% of the US GDP in 2022, up from 17.6% in 2019. Additionally, healthcare costs are rising in a number of countries, including Brazil and India. Thus, the adoption of sophisticated medical facilities will be greatly influenced by the rising costs of healthcare. Therefore, the expansion of the contrast media market is anticipated to be driven by countries' increased healthcare spending in order to improve the healthcare infrastructure, satisfy patients' increasing needs, and provide cutting-edge medical treatment.

Contrast Media Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2025-2032)

Based on product segmentation, the iodinated was predicted to show maximum market share in the year 2024

Based on route of administration segmentation, intravenous was the leading segment in 2024

Based on application segmentation, neurological disorders were the leading segment in 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Contrast Media Market- Segmentation Analysis:

The Global Contrast Media Market is segmented on the basis of Product, Modality, Route of Administration, Application, End-use, and Region.

On the basis of product, the market is segregated into Microbubble, Iodinated, Gadolinium-Based, and Barium-Based. In 2024, the market was dominated by the iodinated category, ascribed to the widespread use of CT and X-ray techniques as well as the accessibility of stable, nonionic iodinated substances for better diagnosis. Although barium-based contrast media are sometimes used for oral and rectal delivery, iodinated contrast media are typically given intravenously. CT and X-ray pictures are improved by using contrast media based on iodine. Additionally, they are employed to improve the imaging of the brain, soft tissues, arteries and veins, internal organs, and the gastrointestinal tract. In addition to cancer, iodinated contrasting media can be used for a wide range of indications, such as neurological, gastrointestinal, nephrological, cardiovascular, and musculoskeletal problems.

Based on application, the market is divided into Musculoskeletal Disorders, Cancer, Nephrological Disorders, Cardiovascular Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others. In 2024, the neurological disorders category held a dominant market share. Since MRI contrast media produce superior images of brain structures than CT, their use is encouraged by diagnostic evaluation of the central nervous system for neurological illnesses. Gadolinium-based contrast agents are used to visualize demyelinated, inflammatory, and neoplastic lesions. In one in three MRIs, gadolinium-based contrast agents are employed to improve picture quality. By making blood vessels, inflammation, and tumours more visible, these contrast agents increase the accuracy of the diagnosis. The three most often used macrocyclic gadolinium-based contrast agents in the United States for the diagnosis of neurological diseases are Gadavist, Dotarem, and Prohance. Adults and children two years of age and up may get them intravenously to view abnormally vascularized brain, spine, and related tissue abnormalities.

Contrast Media Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Contrast Media. The increased funding for biomedical research from both government and non-governmental groups is largely responsible for the market's rise. On October 3, 2022, for instance, SNMMI announced a US$100,000 award for nuclear medicine imaging research and development to address lobular mammary neoplasia. This is anticipated to lead to significant expansion. Increased financing in the area enables a lot of research projects, which will lead to more creative ideas for new product releases that require contrast media. Additionally, the growing number of start-ups investing in medical devices is another driver driving the rise of market revenue in this region.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. This is because healthcare infrastructures are getting better, and people are becoming more conscious of the importance of early diagnosis. Furthermore, another reason propelling the growth of this region's market revenue is the rising prevalence of chronic ailments like cancer, neurological disorders, intestinal illnesses, and cardiovascular diseases (CVDs). In India, for example, non-communicable diseases accounted for 63% of all deaths, with cardiovascular diseases accounting for 27% of these deaths, according to the World Health Organization (WHO). Moreover, The number of innovative molecular imaging techniques generated is anticipated to be significantly impacted by the growing number of startups. Throughout the projection period, they are also expected to accelerate market expansion.

Contrast Media Market- Competitive Landscape:

Major companies such as Bayer AG, General Electric Company, Jodas Expoim Pvt. Ltd., Lantheus, and Guerbet, among others, are using strategies including mergers, acquisitions, and partnerships to grow their market share. Additionally, they are launching new products. To increase their customer bases and market shares internationally, major firms are pursuing mergers and acquisitions. Acquisitions provide companies with a better portfolio and a wider geographic reach, which helps them expand their footprint. Disease indication extension is prevalent in this industry since it enables companies to gain the confidence of particular demographic groups. Through approvals for certain indications, businesses can boost the adoption of their products and target specific patient segments. For instance, in April 2023, by launching Pixxoscan (gadobutrol), a macrocyclic, non-ionic gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI), GE HealthCare broadened its range of contrast media. Pixxoscan obtained marketing clearance in Austria after undergoing regulatory evaluation through a decentralized procedure (DCP).

Recent Development

August 2024: Bayer AG said that a Phase III clinical trial for a new gadolinium-based contrast agent with a better relaxivity and safety profile had been completed. This agent may provide improved MRI imaging capabilities for neurological applications.

April 2024: A novel AI-powered contrast media injection device was introduced by GE Healthcare with the goal of enhancing image quality and lowering the risk of contrast-induced nephropathy by optimizing contrast dose and time for customized imaging regimens.

March 2024: The US Food and Drug Administration approved Lantheus Holdings Inc.'s supplemental new drug application (sNDA) for DEFINITY (Perflutren Lipid Microsphere), an ultrasound-enhancing agent intended for use in pediatric patients with poor echocardiograms.

June 2023: The US Food and Drug Administration authorized the iodine-based contrast agents Iopromide-300 and -370 (Ultravist). In addition to mammography and/or ultrasound, the product can be used to visualize known or suspected breast lesions in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTRAST MEDIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bayer AG
  • General Electric Company
  • Jodas Expoim Pvt. Ltd.
  • Lantheus
  • Guerbet
  • SANOCHEMIA Pharmazeutika GmbH
  • TAEJOON PHARM Co. Ltd.
  • Beijing Beilu Pharmaceuticals Company Limited
  • Bracco S.p.A.
  • iMAX Diagnostic Imaging Limited
  • J.B. Chemicals & Pharmaceuticals Limited
  • Nano Therapeutics Pvt Ltd
  • Trivitron Healthcare
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Microbubble
  • Iodinated
  • Gadolinium-Based
  • Barium-Based

GLOBAL CONTRAST MEDIA MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Ultrasound
  • X-ray/Computed Tomography
  • Magnetic Resonance Imaging

GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral Route
  • Intravenous
  • Rectal Route

GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Musculoskeletal Disorders
  • Cancer
  • Nephrological Disorders
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Contrast Media Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Contrast Media Market Snippet by Product
    • 2.1.2. Contrast Media Market Snippet by Modality
    • 2.1.3. Contrast Media Market Snippet by Route of Administration
    • 2.1.4. Contrast Media Market Snippet by Application
    • 2.1.5. Contrast Media Market Snippet by End-use
    • 2.1.6. Contrast Media Market Snippet by Country
    • 2.1.7. Contrast Media Market Snippet by Region
  • 2.2. Competitive Insights

3. Contrast Media Key Market Trends

  • 3.1. Contrast Media Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Contrast Media Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Contrast Media Market Opportunities
  • 3.4. Contrast Media Market Future Trends

4. Contrast Media Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Contrast Media Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Contrast Media Market Landscape

  • 6.1. Contrast Media Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Contrast Media Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Microbubble
    • 7.1.3. Iodinated
    • 7.1.4. Gadolinium-Based
    • 7.1.5. Barium-Based

8. Contrast Media Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Ultrasound
    • 8.1.3. X-ray/Computed Tomography
    • 8.1.4. Magnetic Resonance Imaging

9. Contrast Media Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 9.1.2. Oral Route
    • 9.1.3. Intravenous
    • 9.1.4. Rectal Route

10. Contrast Media Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Musculoskeletal Disorders
    • 10.1.3. Cancer
    • 10.1.4. Nephrological Disorders
    • 10.1.5. Cardiovascular Disorders
    • 10.1.6. Gastrointestinal Disorders
    • 10.1.7. Neurological Disorders
    • 10.1.8. Others

11. Contrast Media Market - By End-use

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Imaging Centers
    • 11.1.4. Others

12. Contrast Media Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Contrast Media Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Contrast Media Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Contrast Media Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Contrast Media Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Contrast Media Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Contrast Media Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Bayer AG
    • 13.2.2. General Electric Company
    • 13.2.3. Jodas Expoim Pvt. Ltd.
    • 13.2.4. Lantheus
    • 13.2.5. Guerbet
    • 13.2.6. SANOCHEMIA Pharmazeutika GmbH
    • 13.2.7. TAEJOON PHARM Co. Ltd.
    • 13.2.8. Beijing Beilu Pharmaceuticals Company Limited
    • 13.2.9. Bracco S.p.A.
    • 13.2.10. iMAX Diagnostic Imaging Limited
    • 13.2.11. J.B. Chemicals & Pharmaceuticals Limited
    • 13.2.12. Nano Therapeutics Pvt Ltd
    • 13.2.13. Trivitron Healthcare
    • 13.2.14. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us